参考文献
(在框内滑动手指即可浏览)
[1] Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden[J]. CA Cancer J Clin, 2019,69(2): 88-112.
[2] Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid,2016, 26(1): 1-133.
[3] 杨华, 陈缘, 董志勇, 等. 中国肥胖代谢外科数据库:2020年度报告[J]. 中华肥胖与代谢病电子杂志, 2021, 7(1): 1-7.
[4] Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors[J]. J Cancer Epidemiol,2013,2013:965212.
[5] Lim H, Devesa SS, Sosa JA, et al. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013[J]. JAMA, 2017,317(13): 1338-1348.
[6] Du L, Li R, Ge M, et al. Incidence and mortality of thyroid cancer in China, 2008-2012[J]. Chin J Cancer Res,2019, 31(1): 144-151.
[7] Kent WD, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease[J]. CMA J,2007,177(11): 1357-1361.
[8] Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis[J]. N Engl J Med, 2014, 371(19): 1765-1767.
[9] Amphlett B, Lawson Z, Abdulrahman GO, et al. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010[J]. Thyroid, 2013,23(11): 1470-1478.
[10] Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis[J]. Am J Surg, 2010, 200(4): 454-461.
[11] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2): 115-132.
[12] Xhaard C, Rubino C, Cléro E, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study[J]. Am J Epidemiol, 2014,180(10): 1007-1017.
[13] Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role[J]. Endocr Relat Cancer,2009,16(4): 1251-1260.
[14] Schmid D, Ricci C, Behrens G, et al. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis[J]. Obes Rev, 2015, 16(12): 1042-1054.
[15] Pappa T, Alevizaki M. Obesity and thyroid cancer: a clinical update[J]. Thyroid,2014,24(2): 190-199.
[16] Harikrishna A, Ishak A, Ellinides A, et al. The impact of obesity and insulin resistance on thyroid cancer: A systematic review[J]. Maturitas, 2019, 125(1):45-49.
[17] Shin HY, Jee YH, Cho ER. Body mass index and incidence of thyroid cancer in Korea: the Korean Cancer Prevention Study-II[J]. J Cancer Res Clin Oncol, 2017, 143(1): 143-149.
[18] Hwang Y, Lee KE, Park YJ, et al. Annual Average Changes in Adult Obesity as a Risk Factor for Papillary Thyroid Cancer: A Large-Scale Case-Control Study[J]. Medicine (Baltimore), 2016,95(9): e2893.
[19] Wu C, Wang L, Chen W, et al. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study[J]. Medicine (Baltimore), 2017,96(9): e6202.
[20] Kim SK, Woo JW, Park I, et al. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma[J]. Thyroid,2016, 26(5): 657-666.
[21] Kim HJ, Kim NK, Choi JH, et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer[J]. Clin Endocrinol (Oxf),2013, 78(1): 134-140.
[22] Harari A, Endo B, Nishimoto S, et al. Risk of advanced papillary thyroid cancer in obese patients[J]. Arch Surg, 2012,147(9): 805-811.
[23] Paes JE, Hua K, Nagy R, et al. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study[J]. J Clin Endocrinol Metab, 2010, 95(9):4244-4250.
[24] Brito H, Santos AC, Preto J, et al. Obesity and cancer: the profile of a population who underwent bariatric surgery[J]. Obes Surg,2021, 31(11): 4682-4691.
[25] 中华人民共和国卫生健康委员会.甲状腺癌诊疗规范(2018年版) [J]. 中华普通外科学文献(电子版),2019,13(1): 1-15.
[26] 中华医学会内分泌学分会,中华医学会外科学分会,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17): 1249-1272.
[27] 中国医师协会外科医师分会甲状腺外科医师委员会,中国研究型医院学会甲状腺疾病专业委员会,中国医学装备协会外科装备分会甲状腺外科装备委员会.超声引导下甲状腺结节细针穿刺活检专家共识及操作指南(2018版)[J]. 中国实用外科杂志, 2018, 38(3): 241-244.
[28] Guan B, Chen Y, Yang J, et al. Effect of Bariatric Surgery on Thyroid Function in Obese Patients: a Systematic Review and Meta-Analysis[J]. Obes Surg,2017,27(12): 3292-3305.
[29] 中华医学会外科学分会甲状腺及代谢外科学组,中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖及2型糖尿病外科治疗指南(2019版)[J]. 中国实用外科杂志, 2019, 39(4): 301-306.
[30] 刘烺飚, 张鹏. 超级肥胖症减重手术的围手术期管理[J]. 中华肥胖与代谢病电子杂志,2019, 5(4): 187-190.
[31] Chereau N, Vuillermet C, Tilly C, et al. Hypocalcemia after thyroidectomy in patients with a history of bariatric surgery[J]. Surg Obes Relat Dis,2017, 13(3): 484-490.
[32] Droeser RA, Ottosson J, Muth A, et al. Hypoparathyroidism after total thyroidectomy in patients with previous gastric bypass[J]. Langenbecks Arch Surg, 2017, 402(2): 273-280.
[33] Wood SG, Kumar SB, Dewey E, et al. Safety of concomitant cholecystectomy with laparoscopic sleeve gastrectomy and gastric bypass: a MBSAQIP analysis[J]. Surg Obes Relat Dis, 2019, 15(6): 864-870.
[34] Clapp B, Lee I, Liggett E, et al. Are concomitant operations during bariatric surgery safe? An analysis of the MBSAQIP database[J]. Obes Surg,2020, 30(11): 4474-4481.
[35] Ebrahim MAK, AlSanea O, Al-Terki AE. Combined surgical approach for obstructive sleep apnea patient[J]. Case Rep Otolaryngol. 2018,2018,4798024.
[36] Krivan MS, Giorga A, Barreca M, Jain VK, Al-Taan OS. Concomitant ventral hernia repair and bariatric surgery: a retrospective analysis from a UK-based bariatric center. Surg Endosc. 2019; 33(3): 705-710.
[37] Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(3): 160-169.
[38] Antoniou SA, Antoniou GA, Koch OO, et al. Laparoscopic versus open obesity surgery: a meta-analysis of pulmonary complications[J]. Dig Surg, 2015, 32(2): 98-107.
[39] Weller WE, Rosati C. Comparing outcomes of laparoscopic versus open bariatric surgery[J]. Ann Surg, 2008,248(1): 10-15.
[40] Yin J, Hou X. Complications of laparoscopic versus open bariatric surgical interventions in obesity management[J]. Cell Biochem Biophys,2014,70(2): 721-728.
[41] Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients[J]. Surg Obes Relat Dis, 2017,13(5): 727-741.
[42] Benmiloud F, Godiris-Petit G, Gras R, et al. Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial[J]. JAMA Surg, 2020,155(2): 106-112.
[43] Dequanter D, Shahla M, Deniz Y, et al. Recalcitrant hypocalcemia after total thyroidectomy and bariatric surgery[J]. B-ent, 2016,12(3): 207-209.
[44] Manco M, Nanni G, Tondolo V, et al. Hypocalcemia complicating near-total thyroidectomy in patients with coexisting lipid malabsorption due to biliopancreatic diversion[J]. Obes Surg,2004,14(10): 1429-1234.
[45] 中华医学会内分泌学分会,中华医学会外科学分会,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012, 28(10): 779-797.
[46] Papoian V, Ylli D, Felger EA, et al. Evaluation of thyroid hormone replacement dosing in overweight and obese patients after a thyroidectomy[J]. Thyroid, 2019,29(11): 1558-1562.
[47] Raftopoulos Y, Gagné DJ, Papasavas P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity[J]. Obes Surg,2004, 14(4): 509-513.
[48] Sawaya RA, Jaffe J, Friedenberg L, Friedenberg FK. Vitamin, mineral, and drug absorption following bariatric surgery[J]. Curr Drug Metab, 2012,13(9): 1345-1355.
[49] Smith A, Henriksen B, Cohen A. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients[J]. Am J Health Syst Pharm, 2011, 68(23): 2241-2247.